Feasibility and Preliminary Effects of the Walking Tall App for Home-Based Gait Training in Parkinson's Disease: A Pilot Study
1 other identifier
interventional
30
1 country
1
Brief Summary
This is a pilot study designed to assess the feasibility, adherence, and preliminary effects of a 6-week home-based gait training intervention using the Walking Tall mobile app in individuals with Parkinson's disease. The app delivers rhythmic auditory cues and motivational verbal prompts to promote gait improvements. Primary outcomes include daily walking duration and step count measured via wearable sensors; secondary outcomes include gait speed, balance, self-reported confidence, and usability.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 29, 2025
CompletedFirst Submitted
Initial submission to the registry
January 25, 2026
CompletedFirst Posted
Study publicly available on registry
February 2, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
February 13, 2026
February 1, 2026
8 months
January 25, 2026
February 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Average Step Count Per Day
Measured via accelerometer
Time Frame: Baseline and 6 weeks
Daily Walking Duration (minutes/week)
Measured using tri-axial accelerometer (Axivity) over 7 days
Time Frame: Baseline and 6 weeks
Secondary Outcomes (3)
Gait Speed (m/s) - single- and dual-task
Time Frame: Baseline and 6 weeks
Short Physical Performance Battery (SPPB)
Time Frame: Baseline and 6 weeks
Timed Up and Go (TUG) - single- and dual-task
Time Frame: Baseline and 6 weeks
Other Outcomes (1)
Self-reported questionnaires: Activities-specific Balance Confidence (ABC)
Time Frame: Baseline and 6 weeks
Study Arms (1)
Walking Tall App Intervention
EXPERIMENTALParticipants will use the Walking Tall smartphone app to complete 4-5 home-based walking sessions per week for 6 weeks. The app provides rhythmic auditory cues and verbal prompts to improve gait quality.
Interventions
Participants will use the Walking Tall smartphone app to complete 4-5 home-based walking sessions per week for 6 weeks. The app provides rhythmic auditory cues and verbal prompts to improve gait quality.
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of idiopathic Parkinson's disease (MDS criteria);
- Hoehn \& Yahr stage II-III (ON-medication state);
- Able to walk independently for ≥5 minutes;
- Stable medication for ≥1 month;
- Currently enrolled in a rehab program at Ezra LeMarpe;
- Able to provide written informed consent;
You may not qualify if:
- Musculoskeletal, neurological, or visual/hearing impairments affecting gait;
- Cognitive impairments or severe behavioral symptoms;
- History of stroke, severe TBI, or brain tumor;
- Cardiovascular contraindications;
- Inability to use a smartphone;
- Participation in other concurrent intervention studies.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tel Aviv Sourasky Medical Center (Ichilov Hospital)
Tel Aviv, 6423906, Israel
Related Publications (1)
Brodie, M. A., & University of New South Wales. (2023, August 7). New app is a step towards helping people with Parkinson's disease walk more confidently. UNSW Newsroom. Retrieved from https://www.unsw.edu.au/newsroom/news/2023/08/new-app-is-a-step-towards-helping-people-with-parkinsons-disease
BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tatyana Gurevich, Prof
Head of the Movement Disorders Unit at Ichilov Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 25, 2026
First Posted
February 2, 2026
Study Start
December 29, 2025
Primary Completion (Estimated)
August 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
February 13, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share